Work

Gemcitabine (G) and irinotecan (CPT-11) as first-line therapy for carcinoma (ca) of unknown primary (CUP): An NCCTG phase II trial

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.13525

Authors: S. G. Holtan, N. R. Foster, C. E. Erlichman, M. Aubry, M. M. Ames, S. Safgren, P. D. Steen, R. F. Morton, D. Graham, M. P. Goetz

Language: English

Topic: Cancer Diagnosis and Treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2260663374

Cites:

Cited by: 1

Related to: 10